- Are you a child or an adolescent, or do you care for someone, living with moderate to severe chronic pain?
- Would you be interested in joining a Patient Advisory Board (PAB) to contribute directly to research, engage with experts, and take part in decision-making processes?
- Are you willing to help make paediatric research more inclusive and patient-centred?
If yes, TEDDY is pleased to invite you to join the Patient Advisory Board (PAB) in the GAPP Study.
General Information
While gabapentin is widely used by paediatric pain specialists with positive results, it has not been formally approved for paediatric use, and no age-appropriate formulation exists across the full paediatric age range. The European Medicines Agency (EMA), Europe’s medicines regulator, has formally recognised the need for regulatory approval of gabapentin in paediatric use.
The GAPP Study is conducted by an international consortium of paediatric hospitals and research institutions across France, Germany, Italy, the Netherlands, and Poland. Eligible participants include young people under 18 years with moderate to severe chronic pain.
Role and Responsibilities of TEDDY in the GAPP Study
TEDDY serves as the sponsor of the GAPP Study, assuming overall responsibility for its scientific, ethical, and organizational oversight.
Furthermore, TEDDY is responsible for the establishment and implementation of the Patient Advisory Board (PAB), a consultative body of young patients and caregivers, designed to integrate the patients’ perspective into all stages of the two-year project.
In this context, TEDDY is responsible for:
- identifying and engaging PAB members, including young patients, caregivers and members of the YPAGs Young Persons Advisory Groups;
- coordinating and facilitating the PAB’s activities, enabling an effective interaction between participants and study partners;
- ensuring the systematic collection of patient input, promoting a participatory and inclusive approach;
The involvement of the Patient Advisory Board (PAB) in decision-making processes:
As a PAB member, you will have the opportunity to:
- review GAPP research documents;
- co-design outputs that capture young patients’ priorities in managing their condition and participating in research;
- validate research outputs before they are finalised;
- attend face-to-face and virtual meetings with expert;
If you are interested in participating in the Patient Advisory Board (PAB) as part of the GAPP study, please complete the expression of interest form available at the link below by 8 June 2026.
Participation is voluntary and participants may withdraw at any time.
Parental or legal guardian consent is required.
Personal data will be handled confidentially and used solely for recruitment and study purposes.
For more information, please contact scientificsecretariat@teddynetwork.net